Hikma Pharmaceuticals PLC (LSE:HIK)
£ 18.37 0.06 (0.33%) Market Cap: 4.08 Bil Enterprise Value: 4.82 Bil PE Ratio: 27.34 PB Ratio: 2.34 GF Score: 89/100

Hikma Pharmaceuticals PLC Meet the Management Event: Branded Transcript

Jun 22, 2021 / 01:00PM GMT
Release Date Price: £23.98 (+0.71%)
Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

Good morning, and good afternoon, everyone, and welcome to the second event in our 2021 Meet the Management series. I'm Siggi Olafsson, the CEO of Hikma Pharmaceuticals. And today, we will meet the management of Hikma brand business in MENA, in the Middle East and North Africa.

Firstly, this is quite a different business to our injectable division to which we have the last Meet the Management event. As such, we are taking a slightly different approach to this presentation. And alongside our President of MENA, we have invited 2 of our country managers to present to you on the business, and we will also have a short video with contribution from a broader range of MENA management. As before, we are keeping this event relatively short, only 1 hour. A replay will be made available on our website.

Before we start, I would like to remind you and refer you to the safe harbor statement in front of this presentation you see on the screen now. But let's quickly review the agenda. After this intro, I'm delighted to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot